Technical Analysis for ATXI - Avenue Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| New Downtrend | Bearish | 0.00% | |
| 180 Bearish Setup | Bearish Swing Setup | 0.00% | |
| Expansion Breakdown | Bearish Swing Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Possible Inside Day | about 12 hours ago |
| Up 2% | about 13 hours ago |
| Up 1% | about 13 hours ago |
| Gap Down Closed | about 17 hours ago |
| 2x Volume Pace | about 17 hours ago |
Get a Trading Sidekick!
- Earnings date: 05/10/2024
Avenue Therapeutics, Inc. Description
Avenue Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in acquiring, licensing, developing and commercializing products principally for use in the acute or intensive care hospital setting. Its product candidate is intravenous (IV) Tramadol, an intravenous formulation of tramadol hydrochloride (HCl), for the management of moderate to moderately severe postoperative pain. Tramadol, a synthetic dual-acting opioid, is a centrally acting analgesic with weak opioid agonist properties. It also works via the inhibition of serotonin and noradrenaline re-uptake and blocking nociceptive impulses at the spinal level. Tramadol is also combined with acetaminophen (APAP) or nonsteroidal anti-inflammatory drugs (NSAIDS) in clinical practice. During the year ending December 31, 2016, the Company had completed a pharmacokinetics (PK) study for IV Tramadol in healthy volunteers.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Drugs Chemical Compounds Chloride Opioids Analgesics Amines Neurochemistry Hepatotoxins Pharmacokinetics Paracetamol Nonsteroidal Anti Inflammatory Drug
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 93.75 |
| 52 Week Low | 5.78 |
| Average Volume | 27,910 |
| 200-Day Moving Average | 31.26 |
| 50-Day Moving Average | 11.08 |
| 20-Day Moving Average | 10.07 |
| 10-Day Moving Average | 9.11 |
| Average True Range | 1.42 |
| RSI (14) | 1.96 |
| ADX | 29.23 |
| +DI | 0.85 |
| -DI | 19.80 |
| Chandelier Exit (Long, 3 ATRs) | 7.63 |
| Chandelier Exit (Short, 3 ATRs) | 10.04 |
| Upper Bollinger Bands | 12.80 |
| Lower Bollinger Band | 7.35 |
| Percent B (%b) | -0.21 |
| BandWidth | 54.07 |
| MACD Line | -0.95 |
| MACD Signal Line | -0.61 |
| MACD Histogram | -0.3363 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 11.02 | ||||
| Resistance 3 (R3) | 11.41 | 10.20 | 10.21 | ||
| Resistance 2 (R2) | 10.20 | 8.97 | 10.00 | 9.94 | |
| Resistance 1 (R1) | 8.20 | 8.22 | 7.60 | 7.81 | 9.68 |
| Pivot Point | 6.99 | 6.99 | 6.69 | 6.79 | 6.99 |
| Support 1 (S1) | 4.99 | 5.76 | 4.39 | 4.60 | 2.72 |
| Support 2 (S2) | 3.78 | 5.01 | 3.58 | 2.46 | |
| Support 3 (S3) | 1.78 | 3.78 | 2.19 | ||
| Support 4 (S4) | 1.39 |
